Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...

Tardive dyskinesia tends to impact patient quality of life pretty significantly with effects that span physical, psychological, and even social domains. Patients experience functional disability due ...

In 2024, several research and pharmacological advancements were made for tardive dyskinesia, a movement disorder caused by dopamine-blocking medications. Below are some of the highlights of the year.

Dyskinesia refers to uncontrolled, involuntary muscle movements ranging from shakes, tics and tremors to full-body movements. It can happen with various neurological conditions. Another type of ...

Tardive dyskinesia is not typically reversible, but on rare occasions, it can be if caught early and treated immediately. Tardive dyskinesia (TD) is a medication-induced movement disorder involving ...

Tardive dyskinesia shares features with other movement disorders, such as Tourette syndrome and drug-induced Parkinsonism. But a diagnostic evaluation can reveal which condition is causing the ...

Tardive dyskinesia is a movement disorder that causes repetitive, involuntary movements in the face, neck, arms, and legs. The condition is a side effect of certain medications. Symptoms can improve ...